Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Corixa's LeIF adjuvant is protected by three new U.S. patents

March 16, 1999

Spanish market introduction announced for antirejection MAb

March 15, 1999

BTG licenses anti-CD3 antibody to LeukoSite

March 15, 1999

FDA grants fast track designation for pneumococcal conjugate vaccine

March 12, 1999

Zenapax shows positive results in GVHD trial

March 10, 1999

North American Vaccine adds new product to R&D pipeline; U.S. patent issues

March 8, 1999

Licensing opportunity from BTG: fatty acid-peptide conjugates for use in vaccines

March 5, 1999

Epicoat technology granted U.S. patent protection

March 5, 1999

Roche obtains European marketing approval for transplant drug

March 4, 1999

Novel vaccine technology available for licensing from BTG

March 4, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026